Introduction to the Five Most Prevalent Cancers | Reference Price¥1710
-
lung cancerThe incidence and mortality rates of lung cancer in China are the highest among the incidence and deaths of malignant tumors in China. The overall 5-year survival rate is 29.6%. Among them, the 5-year survival rate of early-stage patients can reach 92%, intermediate-stage patients is 29.6%, and the rate drops to 9.8% for advanced-stage patients.
-
gastric cancerChina is one of the countries in the world with a high incidence and mortality rate of gastric cancer . The overall 5-year survival rate is 41.1%.The 5-year survival rate for patients with early gastric cancer is 80.1%, intermediate stage is 41%, and advanced stage is 7.1%.
-
liver cancerThe incidence and mortality rates of liver cancer in China account for the third largest number of malignant tumors. The overall 5-year survival rate is 21.5%. The 5-year survival rate for patients with early-stage hepatocellular carcinoma is 80%, intermediate-stage is 22.5%, and advanced-stage is 4.4%.
-
esophageal cancerEsophageal cancer is a common malignant tumor of the digestive system in China, and China is in the high incidence of esophageal cancer in the world. The overall 5-year survival rate is 23.3%. The 5-year survival rate for patients with early esophageal cancer is 90%, intermediate stage is 27.9%, and advanced stage is 15%.
-
colorectal cancerThe population-standardized incidence of colorectal cancer in our country is characterized by a higher incidence in men than in women. The overall 5-year survival rate was 65.81 TP3T. 5-year survival rates were 91.81 TP3T for early-stage patients, 65.81 TP3T for intermediate-stage, and 17.11 TP3T for advanced-stage.
General information
-
Negative Population Guidance Recommendations
The screening results were negative, no tumor-related gene mutations and methylation abnormalities were detected, and the current risk of suffering from core high-incidence tumors is low. However, it is still necessary to pay attention to health, maintain good living habits and stay away from cancer-causing factors.
-
Recommendations for guidance of weakly positive people
Weakly positive screening, gene mutation or methylation abnormality detected in the blood, there is a risk of precancerous lesions, early stage tumors and other core high prevalence tumors. Please have an in-depth medical checkup as recommended by the genetic counselor immediately. Even if there is no positive indication for the time being, you should continue to pay attention to your health, adjust your living habits, strengthen your exercise, and keep away from cancer-causing factors.
-
Positive Population Guidance Recommendations
Positive screening results, tumor-related gene mutation or methylation has reached a high risk, the risk of developing core high-incidence tumors is high. It is recommended to seek immediate medical attention for a comprehensive examination and treatment as prescribed by the doctor after diagnosis, as well as to improve lifestyle habits and be alert to chronic diseases.

